Department of Animal & Avian Sciences, University of Maryland
Research Overview Understanding BPC-157 BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide whose 15-amino-acid sequence was derived from a larger gastric protective protein first characterised by Predrag Sikiric and colleagues at the University of Zagreb in the early 1990s
Anyone considering peptide therapy should do so under the guidance of a healthcare professional experienced in this field, ensuring that the chosen protocol is tailored to individual needs and health goals
Making Your Decision: BPC-157 vs IGF-1 Choosing between BPC-157 and IGF-1or deciding to use bothultimately depends on your individual health profile, goals, and circumstances
General principles of aseptic reconstitution for lyophilised peptides include: Gather equipment: Bacteriostatic water (if available and appropriate), the peptide vial, appropriate syringes, alcohol swabs, and clean gloves